[1] | Williams B, Lima V and Gouws E.(2011) Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV. Current HIV Research. 9(6):367-382. |
[2] | Stringer JSA, Zulu I, Levy J et al.,(2006). Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 296(7): 782-93. |
[3] | Mahy M, Stover J, Stanecki K, Stoneburner R and Tassie JM.(2010). Estimating the impact of antiretroviral therapy: regional and global estimates of life years gained among adults, Sex Transm Infect. 86(Suppl 2):67-71. |
[4] | National Aids Control Organization (NACO), Annual Report, 2011-12. Available athttp://www.nacoonline.org/upload/Publication/Annual%20Report/NACO_AR_Eng%202011-12.pdf (Accessed on 8th July 2012). |
[5] | Turnbull B.W (1974). The Empirical Distribution Function with Arbitrary Grouped, Censored and Truncated Data, Journal of Royal Statistical Society, series B, 38,290-295. |
[6] | De Gruttola V and Lagakos S. (1989). Analysis of doubly censored survival data, with application to AIDS. Biometrics, 45, 1-11. |
[7] | Sun J. (1996) A non-parametric test for interval censored failure time data with application to AIDS studies. Statist Med, 15; 1387-1395. |
[8] | Sun J. (2006). The Statistical Analysis of Interval Censored Failure Time Data. Springer, New York. |
[9] | Kim M.Y and Xue X, (2002). The analysis of multivariate interval censored survival data, Statistics in Medicine, 21: 3715-3726. |
[10] | Grover G and Banerjee T (2011). Estimation of Survival Times of HIV-1 Infected Children for doubly censored data, Electron. J.App.Sta.Anal, vol.4, issue 2,155-163. |
[11] | Grover G and Shakeri N. (2007). Non parametric estimation of survival function of HIV+ patients with doubly censored data. J. Communicable Dis. 39(1): 7-12. |
[12] | Gentleman R and Geyer C.J.(1994). Maximum likelihood for interval censored data: Consistency and Computation. Biometrika. 81, 618-623. |
[13] | Wei L.J (1992) The Accelerated failure time model: a useful alternative to cox regression model in survival analysis. Statistics in Medicine, 11, 1871-1879. |
[14] | Dempster A.P , Laird, N.M and Rubin D.B (1977). Maximum Likelihood from incomplete Data via the EM Algorithm, Journal of the Royal Statistical Society, Series B, 39, 1-38. |
[15] | Hsu C.H, Taylor J.M.G and Murray S (2004). Multiple Imputation For Interval Censored Data With Auxiliary Variables, Working paper;Berkeley Electronic Press, paper 26. |
[16] | Brookmeyer, R and Goedert J.J (1989). Censoring in an epidemic with an application to hemophilia-associated AIDS, Biometrics, 45, 325-335. |
[17] | Law, C and Brookmeyer, R. (1992). Effects of midpoint imputation on the analysis of doubly censored data, Statistics in Medicine, 11: 1569-1578. |
[18] | Cox D.R (1972) Regression Models and Life Tables, Journal of Royal Statistical Society, series B, 20,187-220. |
[19] | Kalbfleish J.D and Prentice R.L. (1980). The Statistical Analysis of Failure Time Data: Wiley, New York. |
[20] | Collett D (2003). Modeling Survival Data in Medical Research, Chapman and Hall, London. |
[21] | Gadpayle AK, Kumar N, Duggal A et al,. (2012) Survival trend and prognostic outcome of AIDS patients according to age, sex, stages and mode of transmission-A retrospective study at ART centre of a tertiary care hospital. JIACM, 13(4): 291-8. |
[22] | Bachani D, Garg R, Rewari BB, et.al.(2010). Two year treatment outcomes of patients enrolled in india’s national first-line antiretroviral therapy programme, National Medical Journal of India. 23(1):7-12. |
[23] | Ghate M, Deshpande S, Tripathy S, et al.(2011). Mortality in HIV infected individuals in Pune, India. Indian J Med Res. 133:414-420. |
[24] | Antiretroviral Therapy Cohort Collaboration.(2008). Life expectance of individuals on combination antiretroviral therapy in high income countries: a collaborative analysis of 14 cohort studies. Lancet, 372(9635): 293-9. |
[25] | Farzadegan H, Hoover DR, Astemborski J, et al.(1998). Sex differences in HIV1 viral load and progression to AIDS. Lancet. 352:1510-1514. |
[26] | Donnelly CA, Bartley LM, Ghani AC, et al.(2005). Gender differences in HIV1 RNA viral loads. HIV Medicine. 6(3):170-178. |
[27] | Remafedi G, Lauer T.(1995). Survival trends in adolescents with human immunodeficiency virus infection. Arch Pediatr Adolesc Med. 149(10):1093-8. |
[28] | Antiretroviral Therapy Cohort Collaboration.(2009). Timing of initiation of antiretroviral therapy in AIDS-free HIV-1 infected patients: a collaborative analysis of 18-HIV cohort studies. Lancet 6736(09) 60612-7. |
[29] | May M, Sterne JA, Sabin C et al.,(2007). Prognosis of HIV-1 infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 21; 1185-97. |
[30] | Johannessen A, Naman E, Ngowi EN et al.,(2008). Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania, BMC Infectious Disease, 8: 52. |
[31] | Mocroft A, Kirk O, Barton SE et al.,(1999). Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group, AIDS, 13: 943-950. |
[32] | Kay R and Kinnersley N (2002). On the use of accelerated failure time model as an alternative to the proportional hazard model in the treatment of time to event data: a case study in influenza, Drug information Journal, vol-36, pp; 571-579. |
[33] | Orbe J, Ferreira E and Nunez-Anton V,(2002). Comparing proportional hazards and accelerated failure time models for survival analysis. Statist Med, 21; 3493-3510. |
[34] | Nardi A and Schemper M (2003). Comparing Cox and Parametric models in clinical studies, Statist. Med, 22: 3597-3610. |